Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03107780
Title Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Cancer Center SUSPENDED Birmingham Alabama 35233 United States Details
UCLA / Jonsson Comprehensive Cancer Center SUSPENDED Los Angeles California 90095 United States Details
Johns Hopkins University/Sidney Kimmel Cancer Center SUSPENDED Baltimore Maryland 21287 United States Details
Massachusetts General Hospital Cancer Center ACTIVE_NOT_RECRUITING Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute SUSPENDED Boston Massachusetts 02215 United States Details
Henry Ford Hospital SUSPENDED Detroit Michigan 48202 United States Details
Memorial Sloan Kettering Cancer Center ACTIVE_NOT_RECRUITING New York New York 10065 United States Details
Wake Forest University Health Sciences RECRUITING Winston-Salem North Carolina 27157 United States Details
University of Pennsylvania/Abramson Cancer Center SUSPENDED Philadelphia Pennsylvania 19104 United States Details
University of Pittsburgh Cancer Institute (UPCI) SUSPENDED Pittsburgh Pennsylvania 15232 United States Details
*Shaded cells indicate that there was no data available from for the field